The implementation of telehealth due to the COVID-19 pandemic helped an FQHC retain patients in its opioid use disorder (OUD) treatment program, ensuring continued access to care, a new study shows. As health care became increasingly virtual during the pandemic, telehealth helped in providing high levels of care to opioid use disorder (OUD) patients, particularly those involved in buprenorphine treatment programs. The study took place at Chambersburg, PA-based Keystone Health, an FQHC that serves about 56,000 patients, 60% of whom come from rural areas. Researchers collected information, including visit dates, progress notes, urine drug tests, current and prior buprenorphine formulation, and dosage, to conduct a retrospective chart review. Read more.